• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纹状体多巴胺摄取与早期帕金森病患者的嗅觉功能障碍。

Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.

机构信息

Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Parkinsonism Relat Disord. 2018 Nov;56:47-51. doi: 10.1016/j.parkreldis.2018.06.022. Epub 2018 Jun 14.

DOI:10.1016/j.parkreldis.2018.06.022
PMID:29925486
Abstract

INTRODUCTION

Olfactory dysfunction is a sensitive biomarker of neurodegeneration and a cardinal premotor symptom of Parkinson's disease (PD). Although several non-motor symptoms of PD have been correlated with decreased dopamine transporter uptake, olfactory dysfunction and reduced dopamine transporter uptake have not been widely investigated in PD. In this study, we aimed to identify the dopamine transporter status of the corpus striatum and thalamus using a magnetic resonance imaging (MRI)-guided spatial normalization method in patients with PD according to olfactory function.

METHODS

Among 87 PD patients, 50 had hyposmia and 37 had normosmia. All patients underwent positron emission tomography (PET) using F-N-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane (F-FP-CIT) and T1-weighted MRI. PET images were normalized with simultaneously performed spatially normalized MRI and the regional standardized uptake value ratios (SUVR) with a volume of interest template were compared according to olfactory function.

RESULTS

The bilateral caudates and the left anterior and posterior putamen of the hyposmic group showed significantly reduced dopamine transporter uptake compared to the normosmic group. In partial correlation coefficient analysis, olfactory identification impairment was correlated with the SUVR values of the caudate nuclei.

CONCLUSION

More dopaminergic impairment of the bilateral caudate nuclei was found in hyposmic PD. This finding suggests that decreased dopamine uptake in the caudate nucleus may be an imaging trace of olfactory dysfunction in patients with PD.

摘要

简介

嗅觉功能障碍是神经退行性变的敏感生物标志物,也是帕金森病(PD)的主要运动前期症状。尽管 PD 的几种非运动症状与多巴胺转运体摄取减少有关,但嗅觉功能障碍和多巴胺转运体摄取减少在 PD 中尚未得到广泛研究。在这项研究中,我们根据嗅觉功能,旨在通过 MRI 引导的空间归一化方法来确定 PD 患者纹状体和丘脑的多巴胺转运体状态。

方法

在 87 名 PD 患者中,50 名患者存在嗅觉减退,37 名患者嗅觉正常。所有患者均接受 F-N-(3-氟丙基)-2β-碳乙氧基-3β-(4-碘苯基)-nortropane(F-FP-CIT)正电子发射断层扫描(PET)和 T1 加权 MRI。通过同时进行空间归一化 MRI 将 PET 图像归一化,并根据嗅觉功能比较感兴趣区模板的区域标准化摄取比值(SUVR)。

结果

嗅觉减退组的双侧尾状核和左侧前、后壳核的多巴胺转运体摄取明显低于嗅觉正常组。在偏相关系数分析中,嗅觉识别障碍与尾状核 SUVR 值相关。

结论

在嗅觉减退的 PD 患者中发现双侧尾状核的多巴胺能损伤更大。这一发现表明,尾状核中多巴胺摄取的减少可能是 PD 患者嗅觉功能障碍的影像学痕迹。

相似文献

1
Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.纹状体多巴胺摄取与早期帕金森病患者的嗅觉功能障碍。
Parkinsonism Relat Disord. 2018 Nov;56:47-51. doi: 10.1016/j.parkreldis.2018.06.022. Epub 2018 Jun 14.
2
"Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.首发帕金森病伴发抑郁患者尾状核和腹侧纹状体多巴胺转运体的可利用性。
Neurobiol Dis. 2019 Dec;132:104563. doi: 10.1016/j.nbd.2019.104563. Epub 2019 Aug 1.
3
Striatal dopamine activity and myocardial I-metaiodobenzylguanidine uptake in early Parkinson's disease.纹状体多巴胺活性与早期帕金森病患者心肌 I-间位碘苄胍摄取。
Parkinsonism Relat Disord. 2019 Jun;63:156-161. doi: 10.1016/j.parkreldis.2019.02.012. Epub 2019 Feb 14.
4
Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.计算机断层扫描引导的多巴胺转运体正电子发射断层扫描图像空间归一化方法的可行性
PLoS One. 2015 Jul 6;10(7):e0132585. doi: 10.1371/journal.pone.0132585. eCollection 2015.
5
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.路易体痴呆和帕金森病中的纹状体多巴胺转运体:一项比较研究
Neurology. 2004 May 11;62(9):1568-72. doi: 10.1212/01.wnl.0000123248.39847.1d.
6
Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.健康受试者中多巴胺转运体的可用性与嗅觉功能的相关性。
Eur Radiol. 2018 Apr;28(4):1756-1760. doi: 10.1007/s00330-017-5147-7. Epub 2017 Nov 21.
7
Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson's disease.帕金森病运动亚型的嗅觉功能障碍与纹状体多巴胺转运体结合。
Neurol Sci. 2022 Aug;43(8):4745-4752. doi: 10.1007/s10072-022-06110-y. Epub 2022 May 4.
8
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.特发性快速眼动睡眠行为障碍患者黑质纹状体功能的连续多巴胺转运体成像:一项前瞻性研究。
Lancet Neurol. 2011 Sep;10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1. Epub 2011 Jul 28.
9
Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.利用[18F]CFT正电子发射断层扫描(PET)研究帕金森病纹状体亚区域多巴胺能功能减退的进展
Synapse. 2003 Jun 1;48(3):109-15. doi: 10.1002/syn.10192.
10
The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism.药物诱导性帕金森病中嗅觉功能和纹状体多巴胺能系统的状态。
J Neurol. 2010 Nov;257(11):1882-9. doi: 10.1007/s00415-010-5631-3. Epub 2010 Jul 16.

引用本文的文献

1
Longitudinal decline in striatal DAT binding in LRRK2 Parkinson's disease: connections with CSF α-synuclein seeding activity.LRRK2帕金森病中纹状体多巴胺转运体结合的纵向下降:与脑脊液α-突触核蛋白种子活性的关联
J Neurol. 2025 Sep 13;272(9):630. doi: 10.1007/s00415-025-13359-8.
2
Imaging advances to detect non-motor prodromal markers of Parkinson's disease and explore therapeutic translation opportunities.成像技术的进展用于检测帕金森病的非运动前驱标志物并探索治疗转化机会。
NPJ Parkinsons Dis. 2025 Jun 18;11(1):174. doi: 10.1038/s41531-025-01004-0.
3
Unraveling olfactory subtypes in Parkinson's disease and their effect on the natural history of the disease.
解析帕金森病中的嗅觉亚型及其对疾病自然史的影响。
J Neurol. 2024 Sep;271(9):6102-6113. doi: 10.1007/s00415-024-12586-9. Epub 2024 Jul 24.
4
Imaging Procedure and Clinical Studies of [F]FP-CIT PET.[F]FP-CIT正电子发射断层扫描的成像程序与临床研究
Nucl Med Mol Imaging. 2024 Jun;58(4):185-202. doi: 10.1007/s13139-024-00840-x. Epub 2024 Jan 17.
5
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.疾病进展建模揭示了路易体型 α-突触核蛋白病理轨迹的异质性。
Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x.
6
Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.突触前多巴胺能正电子发射断层扫描成像在帕金森症中的应用进展
Neural Regen Res. 2025 Jan 1;20(1):93-106. doi: 10.4103/1673-5374.391180. Epub 2023 Dec 21.
7
The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks.载脂蛋白 E ε4 等位基因和嗅觉功能对气味识别网络的影响。
Brain Behav. 2024 May;14(5):e3524. doi: 10.1002/brb3.3524.
8
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease.帕金森病患者嗅觉功能障碍的临床特征和神经生化机制。
J Neurol. 2024 Apr;271(4):1959-1972. doi: 10.1007/s00415-023-12122-1. Epub 2023 Dec 27.
9
Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson's disease.在帕金森病小鼠模型中,黑质中的多巴胺能神经变性与嗅觉功能障碍有关。
Cell Death Discov. 2023 Oct 21;9(1):388. doi: 10.1038/s41420-023-01684-8.
10
The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review.磁共振成像在检测神经退行性疾病相关生物标志物中的关键作用:综述。
Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.